The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 18475139)

Published in J Hypertens on June 01, 2008

Authors

Peter M Nilsson1, Empar Lurbe, Stéphane Laurent

Author Affiliations

1: Department of Clinical Sciences, University Hospital, Lund University, Malmo, Sweden. Peter.Nilsson@med.lu.se

Articles citing this

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11

The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. Eur Heart J (2009) 1.10

The EPICure study: association between hemodynamics and lung function at 11 years after extremely preterm birth. J Pediatr (2012) 0.85

Diabetes, hypertension, and outcome studies: overview 2010. Diabetes Care (2011) 0.84

Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge. Exp Gerontol (2012) 0.83

Increased arterial stiffness and extracellular matrix reorganization in intrauterine growth-restricted fetal sheep. Pediatr Res (2012) 0.83

Maternal alcohol intake and offspring pulse wave velocity. Neonatology (2009) 0.82

Early accelerated senescence of circulating endothelial progenitor cells in premature coronary artery disease patients in a developing country - a case control study. BMC Cardiovasc Disord (2013) 0.81

Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA). Aging Dis (2014) 0.81

Why should we screen for arterial hypertension in children and adolescents? Pediatr Nephrol (2017) 0.80

Impact of the AGTR1 A1166C polymorphism on subcortical hyperintensities and cognition in healthy older adults. Age (Dordr) (2014) 0.79

Growing-Related Changes in Arterial Properties of Healthy Children, Adolescents, and Young Adults Nonexposed to Cardiovascular Risk Factors: Analysis of Gender-Related Differences. Int J Hypertens (2016) 0.78

Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes. Int J Cardiol (2016) 0.77

Thoracic and abdominal aortas stiffen through unique extracellular matrix changes in intrauterine growth restricted fetal sheep. Am J Physiol Heart Circ Physiol (2013) 0.77

Stopping the cardiovascular disease continuum: Focus on prevention. World J Cardiol (2010) 0.77

Leukocyte Telomere Length in Young Adults Born Preterm: Support for Accelerated Biological Ageing. PLoS One (2015) 0.77

High Blood Pressure States in Children, Adolescents, and Young Adults Associate Accelerated Vascular Aging, with a Higher Impact in Females' Arterial Properties. Pediatr Cardiol (2017) 0.77

Early vascular phenotypes in the genesis of hypertension. Pediatr Nephrol (2010) 0.76

Factors affecting variability in home blood pressure in patients with type 2 diabetes: post hoc analysis of a cross-sectional multicenter study. J Hum Hypertens (2014) 0.76

Mapping cerebral pulse pressure and arterial compliance over the adult lifespan with optical imaging. PLoS One (2017) 0.76

Hyperelastic remodeling in the intrauterine growth restricted (IUGR) carotid artery in the near-term fetus. J Biomech (2013) 0.76

Assessment of ten trace elements in umbilical cord blood and maternal blood: association with birth weight. J Transl Med (2015) 0.75

Hypertension and diabetes: should we treat early surrogates? What are the cons? Diabetes Care (2009) 0.75

Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing. J Clin Diagn Res (2015) 0.75

A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention. Hippokratia (2011) 0.75

Determination of hyperelastic properties for umbilical artery in preeclampsia from uniaxial extension tests. Eur J Obstet Gynecol Reprod Biol (2013) 0.75

Articles by these authors

(truncated to the top 100)

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension (2002) 6.06

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87

European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet (2010) 3.36

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32

Aortic stiffness measurement improves the prediction of asymptomatic coronary artery disease in stroke/transient ischemic attack patients. Int J Stroke (2013) 2.07

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens (2011) 1.89

Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension (2010) 1.85

Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J Hypertens (2012) 1.59

Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens (2003) 1.59

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58

Carotid and aortic stiffness: determinants of discrepancies. Hypertension (2006) 1.56

Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49

Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging. JACC Cardiovasc Imaging (2011) 1.48

True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence. J Hypertens (2015) 1.47

Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47

Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension (2012) 1.43

Lower-extremity arterial stiffness vs. aortic stiffness in the general population. Hypertens Res (2013) 1.41

Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int (2012) 1.38

Hypertension in children and adolescents. J Hypertens (2004) 1.38

Arterial remodeling associates with CKD progression. J Am Soc Nephrol (2011) 1.32

Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension (2009) 1.25

Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J (2012) 1.21

High blood pressure in children: clinical and health policy implications. J Clin Hypertens (Greenwich) (2010) 1.18

Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension (2007) 1.08

Is hypertension associated with an accelerated aging of the brain? Hypertension (2014) 1.04

Large-vessel correlates of cerebral small-vessel disease. Neurology (2013) 1.04

Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. J Ultrasound Med (2010) 1.04

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens (2014) 1.03

Pharmacological modulation of arterial stiffness. Drugs (2011) 1.03

Characterization of arterial wall mechanical behavior and stresses from human clinical data. J Biomech (2008) 1.01

Increased carotid wall stress in vascular Ehlers-Danlos syndrome. Circulation (2004) 1.00

Procedure to consistently obtain endothelial and smooth muscle cell cultures from umbilical cord vessels. Transl Res (2007) 1.00

Multiaxial mechanical characteristics of carotid plaque: analysis by multiarray echotracking system. Stroke (2006) 0.99

Guidelines from the British Hypertension Society. BMJ (2004) 0.98

Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation (2003) 0.94

Disruption of the elastin gene in adult Williams syndrome is accompanied by a paradoxical reduction in arterial stiffness. Clin Sci (Lond) (2002) 0.93

Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs. Fundam Clin Pharmacol (2008) 0.93

Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med (2012) 0.93

Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension (2006) 0.92

Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest (2005) 0.92

Carotid plaque, arterial stiffness gradient, and remodeling in hypertension. Hypertension (2008) 0.91

Cardiovascular risk assessment through target organ damage: role of carotid to femoral pulse wave velocity. Clin Exp Pharmacol Physiol (2008) 0.91

Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey. J Hypertens (2011) 0.89

Arterial remodeling and stiffness in patients with pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol (2003) 0.89

Rationale, design and methods of the CASHMERE study. Fundam Clin Pharmacol (2004) 0.88

Eponym : Grisel syndrome. Eur J Pediatr (2011) 0.88

Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy. AIDS (2006) 0.88

Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet (2011) 0.87

Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol (2010) 0.87

Carotid artery mechanical properties and stresses quantified using in vivo data from normotensive and hypertensive humans. Biomech Model Mechanobiol (2011) 0.86

Exercise intervention in childhood obesity: a randomized controlled trial comparing hospital-versus home-based groups. Acad Pediatr (2012) 0.85

Contrasting circadian rhythms of blood pressure among inbred rat strains: recognition of dipper and non-dipper patterns. J Hypertens (2004) 0.85

Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia. J Hypertens (2004) 0.85

Birth weight and characteristics of endothelial and smooth muscle cell cultures from human umbilical cord vessels. J Transl Med (2009) 0.85

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85

Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens (2010) 0.84

Childhood blood pressure: a window to adult hypertension. J Hypertens (2003) 0.83

Reference values for local arterial stiffness. Part A: carotid artery. J Hypertens (2015) 0.83

Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension (2007) 0.83

Arterial stiffness parameters: how do they differ? Atherosclerosis (2013) 0.83

Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease. J Hypertens (2008) 0.83

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens (2016) 0.83

Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol (2012) 0.83

Differences in emotion processing in patients with essential and secondary hypertension. Am J Hypertens (2010) 0.83

Pulse wave velocity is associated with early clinical outcome after ischemic stroke. Atherosclerosis (2012) 0.82

ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients. High Blood Press Cardiovasc Prev (2014) 0.82

Angiotensinogen gene M235T polymorphism and reduction in wall thickness in response to antihypertensive treatment. Clin Sci (Lond) (2003) 0.82

Surrogate measures of arterial stiffness: do they have additive predictive value or are they only surrogates of a surrogate? Hypertension (2006) 0.82

Arterial stiffness as an imaging biomarker: are all pathways equal? Hypertension (2013) 0.81

Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens (2010) 0.81

In utero exposure to maternal diabetes impairs vascular expression of prostacyclin receptor in rat offspring. Diabetes (2010) 0.81

Large artery stiffness and hypertension after antiangiogenic drugs: influence on cancer progression. J Hypertens (2015) 0.81

Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study. J Inorg Biochem (2013) 0.80

Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. J Hypertens (2006) 0.80

Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria. Adv Ther (2009) 0.80

Association of menopause and hormone replacement therapy with large artery remodeling. Fertil Steril (2011) 0.80

Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease. Eur J Prev Cardiol (2011) 0.80

Reference blood pressure values in childhood: an issue to be solved. J Hypertens (2012) 0.79

Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure. J Hypertens (2014) 0.79

Arterial stiffness: intermediate or surrogate endpoint for cardiovascular events? Eur Heart J (2005) 0.79

The kidney in obesity. Curr Hypertens Rep (2015) 0.79

Thromboangiitis obliterans and endothelial function. Eur J Clin Invest (2010) 0.79

Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging. J Hypertens (2015) 0.78

Lowering of brachial pulse pressure in 9379 hypertensives with type 2 diabetes and reduction of cardiovascular events. Blood Press (2008) 0.78

Hypertension and target organ damage in children and adolescents. J Hypertens (2007) 0.78

Increased stiffness of the carotid wall material in patients with spontaneous cervical artery dissection. Stroke (2004) 0.78

Coronary artery disease. Are β-blockers truly helpful in patients with CAD? Nat Rev Cardiol (2012) 0.78

Reference values for local arterial stiffness. Part B: femoral artery. J Hypertens (2015) 0.78

Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes. J Hypertens (2008) 0.77

Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease? Curr Hypertens Rep (2004) 0.77

Body weight variation and control of cardiovascular risk factors in essential hypertension. Blood Press (2009) 0.77

Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease. Nephrol Dial Transplant (2009) 0.77

Emotional Eating Scale for children and adolescents: psychometric characteristics in a Spanish sample. J Clin Child Adolesc Psychol (2011) 0.77

Influence of obesity in central blood pressure. J Hypertens (2015) 0.76

How to estimate central pressure augmentation? J Hypertens (2007) 0.76

Childhood blood pressure: trends and future tracks. Hypertension (2013) 0.76